logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Oklahoma Cancer Specialists and Research Institute (OCSRI)

+19185053200
Source: Site record.
https://ocsri.org/locations

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Oklahoma’s largest and most integrated cancer care facility in the region. Built by the region's largest group of private physicians, we have the most cancer specialists under one roof. The center combines advanced care, tranquility, wellness amenities, and cutting-edge tech for supportive treatment.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Google. Gynecologist
Source: Google. Laboratory
Source: Google. Pharmacy
Source: Google. Radiologist
Source: Google. Research institute
Source: Trial-derived.
239Total Trials
Source: Trial-derived.
23Recruiting Trials
Source: Trial-derived.
109Active Trials
Source: Trial-derived.
89Completed Trials
Source: Trial-derived.
1021Unique Conditions
Source: Trial-derived.
97Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Recurrent Ovarian Carcinoma (13)Source: Trial-derived. Ovarian Cancer (10)Source: Trial-derived. Recurrent Fallopian Tube Carcinoma (9)Source: Trial-derived. Recurrent Squamous Cell Lung Carcinoma (9)Source: Trial-derived. Breast Cancer (8)Source: Trial-derived. Recurrent Primary Peritoneal Carcinoma (8)Source: Trial-derived. Cervical Cancer (7)Source: Trial-derived. Endometrial Cancer (7)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (149)Source: Trial-derived. NRG Oncology (36)Source: Trial-derived. SWOG Cancer Research Network (21)Source: Trial-derived. GOG Foundation (20)Source: Trial-derived. Merck Sharp & Dohme LLC (20)Source: Trial-derived. Alliance for Clinical Trials in Oncology (17)Source: Trial-derived. European Network of Gynaecological Oncological Trial Groups (ENGOT) (13)Source: Trial-derived. Gynecologic Oncology Group (13)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. PET-CT
Source: AI-inferred. Echocardiography
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Biobanking
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intensity-modulated radiation therapy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cystoscopy
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. Electronic trial enrollment system
Source: AI-inferred. Fluorescence in situ hybridization (FISH) cytogenetic testing
Source: AI-inferred. HIV viral load testing